MAXIPIME

This brand name is authorized in Estonia, Hong Kong SAR China, Japan, Lithuania, Mexico, South Africa.

Active ingredients

The drug MAXIPIME contains one active pharmaceutical ingredient (API):

1	Cefepime dihydrochloride monohydrate UNII 2A1O4F5N0C - CEFEPIME HYDROCHLORIDE ANHYDROUS
	Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.
	Read more about Cefepime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DE01	Cefepime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1024670
HK	Department of Health Drug Office	39153
JP	医薬品医療機器総合機構	6132425D1024, 6132425D2020
LT	Valstybinė vaistų kontrolės tarnyba	1011943
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	128M95
ZA	Health Products Regulatory Authority	28/20.1.1/0722, 28/20.1.1/0723, 28/20.1.1/0724